Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Prostate Carcinoma”

607 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 607 results

Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Looking for participantsNCT07025369
What this trial is testing

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

Who this might be right for
Prostate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+1 more
Mayo Clinic 30
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Large-scale testing (Phase 3)Study completedNCT00936390
What this trial is testing

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,538
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Large-scale testing (Phase 3)Study completedNCT00331773
What this trial is testing

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,116
Not applicableEnded earlyNCT00244894
What this trial is testing

Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer

Who this might be right for
FatigueHot FlashesProstate Cancer
OHSU Knight Cancer Institute 22
Large-scale testing (Phase 3)Study completedNCT00002881
What this trial is testing

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT03763851
What this trial is testing

Cannabis Oil and Radiation Therapy for the Management of Pain

Who this might be right for
Metastatic Prostate CancerLung CancerBreast Cancer
Tetra Bio-Pharma 100
Large-scale testing (Phase 3)Study completedNCT00134056
What this trial is testing

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
SWOG Cancer Research Network 1,038
Not applicableStudy completedNCT00869739
What this trial is testing

Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer

Who this might be right for
Cancer SurvivorDepressionGastrointestinal Complications+4 more
East Carolina University 112
Testing effectiveness (Phase 2)Study completedNCT01251861
What this trial is testing

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaStage I Prostate Cancer AJCC v7Stage IIA Prostate Cancer AJCC v7+2 more
National Cancer Institute (NCI) 108
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Large-scale testing (Phase 3)Study completedNCT04838613
What this trial is testing

Study of Diagnostic Performance of [18F]CTT1057 in BCR

Who this might be right for
Prostatic NeoplasmsProstate CancerRecurrence
Novartis Pharmaceuticals 190
Large-scale testing (Phase 3)UnknownNCT00110162
What this trial is testing

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Peter MacCallum Cancer Centre, Australia 2,000
Not applicableLooking for participantsNCT05487846
What this trial is testing

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Who this might be right for
Metastatic Prostate CarcinomaStage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8
Thomas Jefferson University 120
Not applicableUnknownNCT00959023
What this trial is testing

Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 21,000
Large-scale testing (Phase 3)Looking for participantsNCT06470243
What this trial is testing

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
SWOG Cancer Research Network 528
Large-scale testing (Phase 3)Not Yet RecruitingNCT06855589
What this trial is testing

Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Charles LeMoyne Hospital 400
Not applicableActive Not RecruitingNCT04105920
What this trial is testing

Evaluation of the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate Curietherapies

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 162
Next Page